Groupe la Francaise boosted its stake in shares of OR Royalties Inc. (NYSE:OR – Free Report) by 122.2% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 200,000 shares of the basic materials company’s stock after acquiring an additional 110,000 shares during the quarter. Groupe la Francaise’s holdings in OR Royalties were worth $7,591,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. Bank of America Corp DE lifted its stake in shares of OR Royalties by 37.4% in the 1st quarter. Bank of America Corp DE now owns 1,008,086 shares of the basic materials company’s stock valued at $38,327,000 after purchasing an additional 274,486 shares during the last quarter. Janus Henderson Group PLC increased its position in shares of OR Royalties by 63.0% during the 1st quarter. Janus Henderson Group PLC now owns 29,276 shares of the basic materials company’s stock valued at $1,130,000 after purchasing an additional 11,311 shares during the last quarter. Amundi raised its holdings in OR Royalties by 8.4% during the 1st quarter. Amundi now owns 1,151,071 shares of the basic materials company’s stock valued at $43,764,000 after buying an additional 89,202 shares during the period. Parvin Asset Management LLC lifted its position in OR Royalties by 2.2% in the first quarter. Parvin Asset Management LLC now owns 70,250 shares of the basic materials company’s stock worth $2,671,000 after buying an additional 1,500 shares during the last quarter. Finally, EverSource Wealth Advisors LLC lifted its position in OR Royalties by 94.8% in the first quarter. EverSource Wealth Advisors LLC now owns 4,539 shares of the basic materials company’s stock worth $173,000 after buying an additional 2,209 shares during the last quarter. 68.52% of the stock is currently owned by hedge funds and other institutional investors.
OR Royalties Trading Down 3.1%
OR opened at $29.74 on Friday. The company has a market capitalization of $5.57 billion, a price-to-earnings ratio of 22.19 and a beta of 0.74. OR Royalties Inc. has a 12-month low of $27.54 and a 12-month high of $48.06. The business’s fifty day simple moving average is $32.15 and its 200-day simple moving average is $37.57.
OR Royalties Increases Dividend
The firm also recently declared a quarterly dividend, which was paid on Wednesday, July 15th. Stockholders of record on Tuesday, June 30th were issued a $0.065 dividend. The ex-dividend date was Tuesday, June 30th. This represents a $0.26 annualized dividend and a dividend yield of 0.9%. This is an increase from OR Royalties’s previous quarterly dividend of $0.06. OR Royalties’s dividend payout ratio (DPR) is presently 18.66%.
Analyst Upgrades and Downgrades
A number of research analysts have weighed in on OR shares. Jefferies Financial Group cut their price objective on shares of OR Royalties from $40.00 to $34.00 and set a “hold” rating on the stock in a research report on Monday, July 6th. Zacks Research lowered shares of OR Royalties from a “hold” rating to a “strong sell” rating in a report on Monday, July 13th. Royal Bank Of Canada dropped their price target on shares of OR Royalties from $50.00 to $45.00 and set an “outperform” rating for the company in a research note on Thursday, July 9th. Scotiabank cut their price target on shares of OR Royalties from $51.00 to $42.00 and set a “sector perform” rating on the stock in a report on Tuesday, July 14th. Finally, Weiss Ratings downgraded shares of OR Royalties from a “buy (b-)” rating to a “hold (c+)” rating in a report on Friday, July 24th. One equities research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, OR Royalties currently has a consensus rating of “Hold” and a consensus target price of $40.50.
Check Out Our Latest Research Report on OR
OR Royalties Company Profile
OR Royalties PLC (NYSE: OR) is a closed-ended investment company that specializes in acquiring and managing royalty interests in life science and pharmaceutical products. The company provides capital to biotechnology, specialty pharmaceutical and medical device companies in exchange for a share of future sales revenues. By focusing on royalties secured against marketed products, OR Royalties aims to deliver income and growth potential while minimizing the development and commercialization risks typically associated with direct equity stakes.
The company’s core activities include sourcing royalty transactions, structuring bespoke financing solutions and actively monitoring a diversified portfolio of assets.
Read More
- Five stocks we like better than OR Royalties
- Chevron’s Strong Quarter Shows Why It Still Leads the Energy Sector
- Amazon’s Earnings Beat Shows Why AWS Is Back at the Center of the Bull Case
- Apple’s Record Quarter Could Not Outrun Its Guidance Problem
- McKesson’s Compounding Keeps Adding Up
Want to see what other hedge funds are holding OR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for OR Royalties Inc. (NYSE:OR – Free Report).
Receive News & Ratings for OR Royalties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OR Royalties and related companies with MarketBeat.com's FREE daily email newsletter.
